in a crude mitochondrial/synaptosomal preparation.
from rat hypothalamus.
Further subcellular fractionation studies localized a majority of this enzymatic activity to fractions enriched in synaptic vesicles. The a-amidation activity demonstrated optimal activity at pH 7.5 to 8, was stimulated by the presence of copper ions and reduced ascorbate and required the presence of molecular oxygen. Endogenous cY-amidation activity was inhibited by the addition of ascorbate oxidase. Kinetic analyses demonstrated Michaelis-Menten type kinetics for D-Tyr-Val-Gly as the varied substrate with the values of K,,, and V,,,.. increasing as the ascorbate concentration in the reaction increased. A variety of peptides possessing carboxyl-terminal glycine residues were potent inhibitors of the reaction, while peptides lacking a carboxyl-terminal glycine residue were not, suggesting that many glycine-extended peptides may serve as substrates in the a-am&&ion reaction. The characteristics of hypothalamic a-amidation activity are similar to those previously reported for the a-amidation activity in rat pituitary and mouse corticotropic tumor cells suggesting the presence of closely related enzymes in these tissues.
A number of neuroendocrine peptides contain an o-amide moiety at their carboxyl terminal.
In general, the presence of such an a-amide group is essential for optimal biological activity. The occurrence of this post-translational modification is so characteristic of bioactive peptides that Tatemoto (1982) has purified several novel bioactive peptides based solely on the presence of such an amino acid a-amide group. The hypothalamus is a particularly rich source of peptides with a-amide groups including oxytocin, vasopressin, cu-melanocyte-stimulating hormone (a-MSH), ' growth hormoneand corticotropinreleasing factors, as well as luteinizing hormone-and thyrotropin-releasing hormones (for review see Mains et al., 1983) . The amino acid sequences of many precursors to cY-amidated peptides have been elucidated over the past several years (Nakanishi et al., 1979; Amara et al., 1982; Land et al., 1982; Tatemoto, 1982; Yoo et al., 1982) . In every case, the amino acid which ultimately bears the a-amide moiety in the final product 1 I am grateful to Victor May for the electron microscopic analyses. I thank Betty Eipper and Dick Mains for their unlimited encouragement and patience throughout this work, and, along with Sheryl Sato and Errol De Souza, for enlightening scientific discussion and critical reading of the manuscript. This work was supported by grants from Upjohn, by Grants AM-32949 and DA-00266, and by the McKnight Foundation.
' The abbreviations used are: bis-Tris, (bis(2-hydroxyethyl)iminoTris(hydroxymethyl)methane/Tris(hydroxymethyl)aminomethane; DDC, diethyldithiocarbamate; DMPH4, 6, 6, 7, hormone; Na TES, N-(Tris[hydroxymethyl]methyl-2-aminolethanesulfonic acid.
is followed by a glycine residue in the precursor molecule. This observation has led investigators to speculate that the amino nitrogen of the glycyl residue in the precursor serves as the source for the amide nitrogen in the final product. Additional evidence in support of this premise has come from the identification of what appears to be incompletely processed, glycineextended forms of pancreatic polypeptide and a-MSH in cultured cells (Schwartz et al., 1980; Paquette et al., 1981; Eipper et al., 1983a) . Bradbury et al. (1982) desgined a synthetic substrate (D-TyrVal-Gly), based on the carboxyl terminus to the presumed immediate precursor for CX-MSH, to detect a peptide a-amidation activity in porcine pituitary secretory granules. Substrate synthesized with ["Nlglycine was used to demonstrate that the amide nitrogen of the product is derived from the amino nitrogen of the glycine residue present in the precursor.
Recently, Eipper et al. (1983b) have described a peptidylglycine a-amidating activity in secretory granule fractions from rat anterior, intermediate, neural and bovine intermediate pituitary lobes as well as a mouse corticotropic tumor cell line (AtT-20) (Mains et al., 1984) . This activity was stimulated by the presence of copper ions and ascorbate and requires the presence of molecular oxygen. Current data suggest that the substrate specificity for pituitary Lu-amidation activity is very broad (Bradbury et al., 1982; Bradbury and Smyth, 1983; Landymore-Lim et al., 1983) , and similar enzymatic activities have been found in other tissues (Husain and Tate, 1983; Kizer et al., 1984; Myers et al., 1984; Wand et al., 1984) .
The biosynthetic processes involved in the formation of a majority of hypothalamic peptide hormones are just beginning to be elucidated. The majority of the proteolytic cleavages that produce ol-MSH and P-endorphin from pro-ACTH/endorphin in the intermediate lobe of the pituitary do not occur until the prohormone has moved into the secretory granules (Glembotski, 1981 (Glembotski, , 1982 . A similar sequence of processing events for these hormones has also been postulated in the hypothalamus (Barnea et al., 1981) . Thus, any Lu-amidation activity involved in the production of hypothalamic hormones or releasing factors might be expected to exist within the secretory granules (synaptic vesicles). Since the hypothalamus is responsible for the biosynthesis of many peptides which possess a-amide groups, the presence of a peptide a-amidation activity in this tissue was examined. The homogenate was centrifuged at 1,000 x g for 10 min to sediment nuclei and cellular debris (Pl) (Whittaker, 1969) . The volume of the 1,000 X g supernatant fraction (Sl) was adjusted to 10 ml with homogenization buffer, and the supernatant was centrifuged at 20,000 X g for 30 min in a fixed-angle rotor (Beckman, type 50 Ti with 12 strokes at 840 rpm. The homogenate was fractionated by differential centrifugation as described above with the exception that the Pl pellet was washed once by resuspension and centrifugation. The 1,000 x g supernatant fluids (Sl) were then pooled and centrifuged at 20,000 X g for 30 min. The pellet (P2) was gently resuspended in distilled water (2 ml/gm of original tissue) by trituration. This suspension was further fractionated on a discontinuous sucrose density gradient modified from Whittaker et al. (1964 acid), pH 7.0, as noted in the figure legends. In the final assay solution, the stock buffer was usually diluted by about 20%.
Materials and Methods
The reaction was allowed to proceed for 3 to 6 hr and was stopped bv the addition of 1.3 ml of 10 mM sodium nhosnhate. DH 5.0. The diluted samples were then applied to a l.O-ml Column of SP-Sephadex-C25-120 equilibrated with IOmM sodium phosphate, pH 5.0. After washing the column with 9 ml of 10 mM sodium phosphate, pH 5.0, to remove unreacted substrate, the reaction product was eluted with two 1.7-ml aliquots of 0.5 M NaCl in 10 mM sodium phosphate, pH 5.0. Samples were assayed for radioactivity in a gamma scintillation counter (75% efficiency).
Reaction velocities were calculated as previously described (Eipper et al., 1983b) . Specific assay conditions are described in the figure legends.
Columns were recycled for use in subsequent assays by washing the ion-exchange resin with the following: 5 ml of 100 mM NaOH, 10 ml of H,O, 5 ml of 100 mM HaP04, 10 ml of HzO, 5 ml of 200 mM sodium phosphate, pH 5.0, and 5 ml of 10 mM sodium phosphate, pH 5.0; results obtained from columns regenerated in this manner were indistinguishable from results obtain with previously unused ion-exchange resin.
Results
Initial identification of cr-amidation activity in hypothalamic extracts. Preliminary experiments involving the incubation of [1251]-~-Tyr-Val-Gly with whole hypothalamic homogenates or crude subcellular fractions obtained by differential centrifugation were unable to detect the presence of a-amidation activity in this tissue. Previous studies on ol-amidation activity in rat pituitary secretory granules (Eipper et al., 1983b ) demonstrated the occurrence of potent inhibitor(s) of such activity in both whole pituitary homogenates and various Percoll gradient subcellular fractions; the effect of these inhibitors was largely overcome by the addition of exogenous copper (Glembotski et al., 1984) . In addition, ascorbic acid was shown to be a potent stimulator of pituitary oc-amidation activity (Eipper et al., 1983b (Eipper et al., , 1984 Glembotski et al., 1984) . When copper and ascorbic acid were added to incubations with whole hypothalamic homogenates or crude subcellular fractions, it was possible to detect a peptide cY-amidation activity. Addition of optimal concentrations of ascorbic acid (0.625 mM) to crude mitochondrial/synaptosomal fractions resulted in a 43-fold increase in hypothalamic oc-amidation activity. There was no detectable activity in the absence of exogenous copper, so that the foldstimulation upon addition of optimal concentrations of copper (25 FM) was undefined. Subcellular fractionation of hypothalamic tissue revealed that approximately 40% of the total cy-amidation activity could be recovered in a crude mitochondrial/synaptosomal pellet (P2). The majority of the remaining activity (50%) was isolated in the pellet representing nuclei and cellular debris (Pl). Attempts to further homogenize the nuclear pellet, in order to release additional activity, resulted in little increase of LXamidation activity in the crude mitochondrial/synaptosomal fraction and generally caused the solubilization of such activity as it moved from the nuclear pellet to the postmicrosomal supernatant (S3). To establish the incubation times in which steady product formation was occurring, a time course was established using the cY-amidation activity derived from a crude mitochondrial/ (Eipper et al., 1984; Mains et al., 1984) . When the amount of protein from a crude mitochondrial/synaptosoma1 pellet was varied from 1.25 to 22.5 pg, a linear increase in the production of product was observed. Enzyme that was boiled for 5 min before incubation in the cy-amidation reaction showed no detectable activity (less than 0.1% conversion).
To determine whether the radioactivity, which eluted from the cation exchange resin (SP-Sephadex) at high ionic strength (0.5 M NaCl), upon application of the hypothalamic reaction product, represented ['251]-~-Tyr-Val-NHn, such reaction products were analyzed by reversed phase high performance liquid chromatography (Fig. 1) . The radiolabeled product of such (Yamidation assays co-eluted with synthetic mono-['251]-D-TyrVal-NH*, thereby justifying the use of this ion-exchange procedure as an effective means of separating product from unreacted substrate as well as confirming the identity of the hypothalamic a-amidation product. Since a crude preparation of synaptosomes contains a significant amount of other subcellular organelles, it was necessary to further fractionate the crude preparation into its component organelles to remove possible inhibitor (s) to the cu-amidation reaction and to focus on the enzymatic activity involved in the biosynthetic processing of hypothalamic peptide hormones. Characterization of synaptic vesicle-associated a-amidation 1600 1400 '; 1200 (Whittaker et al., 1964 , Tucek, 1966 Whittaker and Barker, 1972; Parker et al., 1978) . Gradient fractions were characterized by radioimmunoassay for pro-ACTH/endorphin-derived 16,000-dalton fragment (a marker for synaptic vesicles), fumarase activity (a marker for mitochondria), protein concentration (Fig. 2) , and electron microscopy. Two major peaks of fumarase activity were observed in the dense region of the gradient (fractions 18 to 22 and fraction 25; bottom). These two regions possess the sedimentation characteristics of subcellular fractions containing partially lysed synaptosomes (fractions 18 to 22) and mitochondria (fraction 25) (Whittaker et al., 1964; Parker et al., 1978) . Pro-ACTH/ endorphin-derived 16,000-dalton fragment immunoreactivity (Fig. 2, top) the breakage of a portion of synaptic vesicles resulting from hypotonic treatment of intact synaptosomes or from subsequent fractionation procedures. Electron microscopic analyses of sucrose gradient fractions confirmed the identity of these subcellular fractions and were consistent with radioimmunological and enzymatic markers.
The distribution of hypothalamic ol-amidation activity paralleled that of 16,000-dalton fragment immunoreactivity (Fig.  2, top) . The majority of the recovered a-amidation activity was associated with the synaptic vesicle fraction (59%) with lesser amounts in the soluble (12%) and synaptosome-associated (19%) regions. The specific activity of cu-amidation activity (picomoles per microgram of protein per hour) in the synaptic vesicle region was 3.3-and 7.3-fold greater than the specific activity of a-amidation activity from the soluble and synaptosomal regions, respectively. A closer comparison of the distribution of oc-amidation activity and 16,000-dalton fragment immunoreactivity
indicates that a-amidation activity is more prevalent in the region of less dense synaptic vesicles (e.g., fraction 9), whereas 16,000-dalton fragment immunoreactivity is relatively enriched in the region of more dense synaptic vesicles (e.g., fraction 15). Those fractions containing the greatest levels of oc-amidation activity (fractions 9 to 13) were pooled, frozen, and thawed five times and designated as the synaptic vesicle fraction for use in further experiments.
A time course for the formation of D-Tyr-Val-NH* utilizing the synaptic vesicle-associated a-amidation activity was linear for at least 7 hr after an initial lag of approximately 30 min. When the amount of synaptic vesicle-associated protein was varied from 0.5 to 16 pg, a linear increase in the production of product was observed. Synaptic vesicle fractions that were boiled for 5 min before incubation in the cu-amidation reaction showed no detectable activity. When the synaptic vesicle-associated a-amidation reaction product (26% conversion) was analyzed by reversed phase high performance liquid chromatography, 99% of the recovered counts eluted the retention time of synthetic ['251]-~-Tyr-Val-NH2 (Overall recovery was 89%; similar to Fig. 1) .
The pH optimum of the synaptic vesicle-associated a-amidation activity was observed to be between 7.5 and 8.0 (Fig. 3) . While the enzymatic activity was totally eliminated at pH 5.5, the velocity of the reaction was decreased by only 53% at pH 10.0.
Copper dependence. The stimulatory effects of copper on pituitary ol-amidation activity have been described previously (Bradbury and Smyth, 1983; Eipper et al., 1983b Eipper et al., , 1984 Glembotski et al., 1984) , and the addition of copper was essential to the detection of a-amidation activity in whole hypothalamic homogenates or crude subcellular fractions. Whereas the presence of an ol-amidation activity in hypothalamic synaptic vesicle fractions can be detected without the addition of copper, such activity is inhibited by the addition of diethyldithiocarbamate (DDC), a divalent cation chelator. The ability of a variety of cations to reverse the inhibitory effect of DDC on rat hypothalamic Lu-amidation activity was determined (Table  I ). Of those metals tested, only copper was capable of reversing the inhibitory effect of DDC. The concentration of copper resulting in maximal stimulation of hypothalamic Lu-amidation activity was determined in several experiments and found to be 25 FM, utilizing a crude synaptosomal preparation as an enzyme source. With purified synaptic vesicles the dose response curve for copper tended to plateau between 5 and 50 pM CuS04 with approximately 30% more activity at 400 ~.LM CuSO,; assays were routinely performed with 12.5 pM CuS04 to avoid the potential inhibitory effects of higher copper levels (Fig. 4) . Optimal copper concentrations varied slightly betwen crude synaptosome and purified synaptic vesicle preparations, indicating the necessity to optimize copper levels for each individual Assays utilizing crude synaptosomal-associated protein as an enzyme source contained [1261]-n-Tyr-Val-Gly, 0.42 pM n-Tyr-Val-Gly, 25 pM CuS04, 0.625 mM ascorbic acid, 100 pg/ml of catalase, and 133 mM Na TES, pH 7.0. Assays were incubated for 3 hr with 18.3 pg of protein/ assay tube under an atmosphere of air or a humidified stream of argon. Assays utilizing synaptic vesicle-associated protein as an enzyme source contained ['251]-n-Tyr-Val-Gly, 0.5 pM n-Tyr-Val-Gly, 12.5 pM CuSO,, 0.625 mM ascorbic acid, 100 pg/ml of catalase, and 69 mM bis-Tris/69 mM Tris-HCl, pH 7.5. Assays were incubated for 3 hr with 2 pg of protein/assay tube under an atmosphere of air or a humidified stream of nitrogen. 2608 oc-' ' ' I 1 I I 0 05 I 5 IO 50 too 500 1000
[CuSoq] (I-'M) Figure 4 . Effect of exogenous copper addition on a-amid&ion activity from rat hypothalamus. Assays utilizing crude synaptosomal-associated protein (0) contained the indicated concentrations of CuSOI, [lZ51]-~-Tyr-Val-Gly, 2.43 pM n-Tyr-Val-Gly, 0.625 mM ascorbic acid, 100 pg/ ml of catalase, and 121 mM Na TES, pH 7.0. Assays were incubated for 4 hr with 8 pg of protein/assay tube. Reaction velocity in the absence of exogenous copper was not detectable; maximal velocity was 0.08 pmol/pg/hr at 25 /IM CuSO+ Assays utilizing synaptic vesicleassociated protein (0) contained the indicated concentrations of CuSOI, ['251]-n-Tyr-Val-Gly, 0.83 pM n-Tyr-Val-Gly, 0.625 mM ascorbic acid, 100 rg/ml of catalase, and 125 mM Na TES, pH 7.5. Assays were incubated for 6.2 hr with 1.9 pg of protein/assay tube. Reaction velocity in the absence of exogenous copper was 0.012 pmol/pg/hr; maximal velocity was 0.23 pmol/pg/hr at 400 PM CuSOI.
preparation.
Similar variations in copper optima have previously been described for both pituitary cy-amidation activity (Eipper et al., 1983b; Mains et al., 1984) and dopamine phydroxylase (Duch et al., 1968; Orcutt and Molinoff, 1976) .
Oxygen dependence.
A number of copper-requiring enzymes are involved in interactions with molecular oxygen (Ullrich and Duppel, 1975; Cass and Hill, 1980; Jameson, 1981) . Based upon the oxygen requirement of the pituitary cY-amidation activity (Eipper et al., 1983b; Mains et al. 1984) , the rate of hypothalamic Lu-amidation was determined in the presence of air (control) or in the presence of a humidified stream of argon or nitrogen (Table II) . When utilizing both crude synaptosomal and synaptic vesicle-associated protein as the source of enzymatic activity, the rate of the reaction in the oxygen-depleted assay tubes dropped to 10 to 20% of the control rate. Hypothalamic peptide a-amidation activity must therefore be dependent upon the presence of molecular oxygen.
Ascorbate dependence.
The fact that hypothalamic a-amidation activity showed a dependence on copper and molecular oxygen, similar to pituitary ol-amidation activity, suggested that ascorbic acid might play an important role in the hypothalamic reaction as it does in the pituitary reaction (Eipper et al., 1983b (Eipper et al., , 1984 Glembotski et al., 1984; Mains et al., 1984) . Various reduced and oxidized flavin, pyridine, and pteridine nucleotides, as well as ascorbate and reduced glutathione, were tested for their ability to stimulate hypothalamic oc-amidation (Table III ). Of those cofactors tested, ascorbate appeared to have the greatest stimulatory effect when utilizing either synaptic vesicle (2-to 7-fold stimulation)
or crude synaptosomal-associated protein of hypothalamic a-amidation activity was determined in several experiments and was found to be 0.625 mM (Fig. 5) . Addition of ascorbate alone, in the absence of catalse, resulted in a dose-dependent inhibition of Lu-amidation activity, as seen for dopamine P-hydroxylase (Friedman and Kaufman, 1965; Diliberto and Allen, 1980) . When catalase concentrations in reaction tubes were varied between 0.4 and 2700 pg/ml, a dose-dependent increase in o(-amidation activity was observed with optimal levels occurring at 300 pg of catalase/ml. In the case of dopamine ,B-hydroxylase, catalase is thought to act by preventing both the auto-oxidation of ascorbate and damage to the enzyme caused by superoxide radical production during such an auto-oxidation event (May et al., 1981; Wong et al., 1981; Scarpa et al., 1983) .
When utilizing a crude synaptosomal fraction as an enzyme source, ascorbate was the most potent stimulator of the (Yamidation reaction, but several other cofactors, including flavin adenine dinucleotide, flavin mononucleotide, and 6, 6, 7, ) , were also effective in stimulating the reaction significantly above control values (data not shown). Except for ascorbic acid, the only cofactor capable of stimulating hypothalamic a-amidation when utilizing purified synaptic vesicles as an enzyme source was the synthetic biopterin analogue DMPH4. The concentration of DMPH, resulting in maximal stimulation of hypothalamic cu-amidation activity (1.7-fold) was determined in several experiments and was found to vary between 200 and 400 PM at pH 7.5.
The ability of increasing concentrations of ascorbate oxidase to diminish synaptic vesicle-associated cy-amidation activity in the absence of exogenous cofactor was assessed (Fig. 6) . As the concentration of ascorbate oxidase in the reaction tubes was increased, the rate of endogenous cY-amidation activity was decreased to 5% of the control value in the absence of ascorbate oxidase. When the rate of hypothalamic Lu-amidation activity in the presence of DMPH, was determined with increasing amounts of ascorbate oxidase, a graded reduction in a-amidation activity was also seen. Concentrations of ascorbate oxidase which resulted in a maximal decrease of oc-amidation activity in the absence of exogenous cofactor decreased the pteridineinduced fold-stimulation by approximately 60%. Substrate specificity. All known precursors to cy-amidated peptides contain a glycine residue immediately following the amino acid which ultimately bears the a-amide moiety (Mains et al., 1983) ; the occurrence of this common amidation "signal" raises the possibility that a single enzymatic activity could account for the cY-amidation of a great variety of cY-amidated peptides from various tissues.
In order to investigate the substrate specificity requirements of the peptide cY-amidation activity found in rat hypothalamus, various peptides (100 pM) were assayed for their ability to inhibit the conversion of ['251]-D-Tyr-Val-Gly into ['251]-~-TyrVal-NH2 (Table IV) ; peptides which can serve as potential substrates of the a-amidation activity instead of D-Tyr-ValGly would be expected to demonstrate such an inhibitory effect. Peptides possessing carboxyl-terminal glycine residues were potent inhibitors of the hypothalamic Lu-amidation reaction. Even those glycine-extended molecules which are not thought to serve as relevant physiological substrates (e.g., ACTH(l-10); Tyr-Gly-Gly)
were capable of such inhibition. Removal of the carboxyl-terminal glycine residue (ACTH(l-13)) or extension of the peptide beyond the glycine moiety (Tyr-Gly-Gly-Phe) greatly diminished the inhibitory effects of these peptides. Vol. 4, No. 10, Oct. 1984 tration of n-Tyr-Val-Gly was increased, the reaction velocity increased in a saturating manner (Fig. 7) . Both LineweaverBurk and Eadie-Hofstee (Fig. 7, inset) analyses of these data demonstrated Michaelis-Menten type kinetics with D-Tyr-ValGly as the varied substrate.
When assayed under optimal conditions, the apparent K,,, for peptide substrate was approximately 2-to 3-fold higher for the crude mitochondria/synaptosomal activity than the apparent K,,, when using the synaptic vesicle-associated a-amidation activity. V,,, values for the crude activity were 5-fold less than the corresponding values obtained for the synaptic vesicle-associated Lu-amidation activity. The addition of increasing concentrations of ascorbic acid to pituitary secretory granule fractions resulted in an increase in oc-amidation reaction velocity at all concentrations of peptide substrate (Eipper et al., 1983b (Eipper et al., , 1984 . The effects of varied concentrations of exogenous ascorbate on the kinetic parameters of the hypothalamic crude synaptosomal a-amidation activity were determined (Table V) . A 4-fold increase in the concentration of ascorbate was accompanied by an 8-fold increase in V,,, and a 4-fold increase in K,. 
